136 Results for "

Free Fatty Acid

" in MedChemExpress (MCE) Product Catalog:
Products (136)

136 Results for "Free Fatty Acid" in MCE Product Catalog:

19
19 Publications Verification
Cat. No.: HY-B0968A
CAS No.: 5011-34-7
Target:  

Autophagy

Research Areas:  

Cardiovascular Disease

Trimetazidine is a selective long chain 3-ketoyl coenzyme A thiolase inhibitor with an IC50 of 75 nM, which can inhibit β-oxidation of free fatty acid (FFA). Trimetazidine is an effective antianginal agent and a cytoprotective agent, has anti-oxidant, anti-inflammatory, antinociceptive and gastroprotective properties. Trimetazidine triggers autophagy. Trimetazidine is also a 3-hydroxyacyl-CoA dehydrogenase (HADHA) inhibitor .
loading...
    loading...
19
19 Publications Verification
Cat. No.: HY-B0968
CAS No.: 13171-25-0
Target:  

Autophagy

Research Areas:  

Cardiovascular Disease

Trimetazidine dihydrochloride is a selective long chain 3-ketoyl coenzyme A thiolase inhibitor with an IC50 of 75 nM, which can inhibit β-oxidation of free fatty acid (FFA). Trimetazidine dihydrochloride is an effective antianginal agent and a cytoprotective agent, has anti-oxidant, anti-inflammatory, antinociceptive and gastroprotective properties. Trimetazidine dihydrochloride triggers autophagy. Trimetazidine dihydrochloride is also a 3-hydroxyacyl-CoA dehydrogenase (HADHA) inhibitor .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-12940
CAS No.: 1391076-61-1
Purity:  98.12%
Research Areas:  

Metabolic Disease

GLPG0974 is a free fatty acid receptor-2 (FFA2/GPR43) antagonist with an IC50 of 9 nM.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-100881
CAS No.: 1374516-07-0
Purity:  99.47%
Research Areas:  

Metabolic Disease

TUG-891 is a potent and selective agonist for the long chain free fatty acid (LCFA) receptor 4 (FFA4/GPR120) .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-N0728
CAS No.: 463-40-1
Synonyms: ALA Free base; C18:3 (9Z,12Z,15Z) Free base; C18:3 n-3 Free base
α-Linolenic acid (ALA (free base); C18:3 (9Z,12Z,15Z) (free base); C18:3 n-3 (free base)) is an essential fatty acid that cannot be synthesized by humans. α-Linolenic acid can affect the process of thrombotic through the modulation of PI3K/Akt signaling. α-Linolenic acid possess the anti-arrhythmic properties and is related to cardiovascular disease and cancer .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-128692
CAS No.: 67769-47-5
Purity:  99.67%
Luc Yellow CH dilithium is a high-intensity fluorescent probe containing free hydrazyl groups. Luc Yellow CH can react with fatty aldehydes at room temperature. Luc Yellow CH serves as a biological tracer to monitor neuronal branching, regeneration, gap junction detection and characterization, and selective ablation of cells after aldehyde fixation. Luc Yellow CH displays the maximum excitation/emission of 430 nm/540 nm, respectively .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-Y0366
CAS No.: 143-07-7
Lauric acid is a middle chain-free fatty acid with strong bactericidal properties. The EC50s for P. acnes, S.aureus, S. epidermidis, are 2, 6, 4 μg/mL, respectively .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-W127715
CAS No.: 71206-95-6
Lucifer Yellow CH dipotassium is a high-intensity fluorescent probe containing free hydrazyl groups. Lucifer Yellow CH can react with fatty aldehydes at room temperature. Lucifer Yellow CH serves as a biological tracer to monitor neuronal branching, regeneration, gap junction detection and characterization, and selective ablation of cells after aldehyde fixation. Lucifer yellow CH displays the maximum excitation/emission of 430 nm/540 nm, respectively .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P1125
CAS No.: 300851-67-6
Research Areas:  

Others

4-CMTB is a selective free fatty acid receptor 2 (FFA2/GPR43) agonist and a positive allosteric modulator (pEC50=6.38) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N7075
CAS No.: 9005-80-5
Inulin is an orally active prebiotic targeting the intestinal microbiota, selectively promoting the proliferation and activity of beneficial bacteria such as bifidobacteria and lactic acid bacteria, and playing a role in regulating the intestinal microecology. The functions of Inulin include: Fermentation by probiotics in the colon to produce short-chain fatty acids (such as butyrate and propionate), lowering the intestinal pH and inhibiting the overgrowth of harmful bacteria; Enhancing the intestinal barrier function and reducing endotoxin translocation; Directly scavenging free radicals (such as superoxide free radicals, hydroxyl free radicals) and activating antioxidant enzymes (SOD, CAT) to reduce oxidative stress. Inulin can also be used in the study of intestinal diseases (constipation, IBD), metabolic syndrome (diabetes, obesity) and liver damage by regulating glucose and lipid metabolism (such as reducing triglycerides, improving insulin sensitivity) and immune response (enhancing NK cell activity, inhibiting inflammatory factors)[1][2][3][4].
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-W016868
CAS No.: 53984-36-4
3-Chloro-5-hydroxybenzoic acid is a potent, orally active and selective lactate receptor GPR81 agonist, with an EC50 of 16 μM for human GPR81. 3-Chloro-5-hydroxybenzoic acid exhibits favorable in vivo effects on lipolysis in a mouse model of obesity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-112813
CAS No.: 2247372-59-2
Purity:  99.42%
Research Areas:  

Metabolic Disease

TUG-1375 is an agonist of free fatty acid receptor 2 (FFA2/GPR43), with a pKi of 6.69. TUG-1375 is inactive on FFA3, FFA4, PPARα, PPARγ, PPARδ, LXRα or LXRβ .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-116522
CAS No.: 1798310-55-0
Purity:  98.29%
AR420626 is a selective agonist of free fatty acid receptor 3 (FFAR3) (IC50=117 nM). AR420626 has anti-inflammatory, anticancer and antidiabetic activities. AR420626 improves neurogenic diarrhea by inhibiting nAChR mediated neural pathways. AR420626 inhibits the growth of HepG2 xenografts and inhibits the proliferation of hepatoma cells by inducing apoptosis. AR420626 also suppresses allergic asthma and eczema and has the ability to activate GPR41 to increase Ca 2+ signal-mediated glucose uptake and improve diabetes .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N2593
CAS No.: 32507-66-7
Isorhapontigenin is an orally active dietary polyphenol. Isorhapontigenin acts as a potent antioxidant that reduces the production of reactive oxygen species (ROS). Isorhapontigenin promotes the binding of JUN to the AP-1 site on the SESN2 promoter, induces SESN2 transcription, triggers MAPK8-dependent JUN activation, and upregulates the expression of PPAR-α, PGC-1α and CPT-1A to facilitate fatty acid oxidation. Isorhapontigenin induces autophagy, apoptosis and preadipocyte differentiation; it inhibits tumor growth, cell invasion, NF-κB transcriptional activity, the PI3K/Akt signaling pathway, STAT1 phosphorylation and MMP-2 expression. Isorhapontigenin alleviates oxidative stress, inflammatory cytokine release and triglyceride accumulation; it increases intracellular ATP levels and promotes Nrf2 nuclear translocation. Isorhapontigenin improves insulin sensitivity in adipose tissue and glucose tolerance, and reduces postprandial blood glucose, insulin and free fatty acid levels. Isorhapontigenin is applicable to research on bladder cancer, liver injury, chronic obstructive pulmonary disease, acute lung injury and type 2 diabetes .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0283
CAS No.: 51037-30-0
Synonyms: K-9321
Target:  

Carbonic Anhydrase

Research Areas:  

Metabolic Disease

Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N1478
CAS No.: 24512-62-7
Gardenoside is an orally active natural compound found in Gardenia fruits. Gardenoside reliefs chronic constriction injury (CCI)-induced neuropathic pain by regulating the P2X3 and P2X7 receptors. Gardenoside has an inhibitory effect on free fatty acids (FFA)-induced cellular steatosis. Gardenoside reduces reactive oxygen species (ROS). Gardenoside can be used for anti-inflammatory, antinociceptive and hepatoprotective study .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-116263
CAS No.: 1322598-09-3
Purity:  99.7%
Research Areas:  

Metabolic Disease

CATPB is a potent, selective free fatty acid receptor 2 (FFA2R/GPR43) antagonist .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-D0842A
CAS No.: 9048-46-8
Synonyms: Bovine Serum Albumin (Low Endotoxin,Fatty Acid Free)
BSA Protein (Low Endotoxin,Fatty acid free) (Bovine Serum Albumin (Low Endotoxin,Fatty acid free)) is a 583 amino acid globular protein and oligonucleotide binding protein composed of three homologous full α domains. BSA Protein (Low Endotoxin,Fatty acid free) blocks the overall binding of oligonucleotides to cells. BSA Protein (Low Endotoxin,Fatty acid free) regulates the development of hamster embryos and induces arthritis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0723
CAS No.: 64809-67-2
Neomangiferin is an orally active natural flavonoid. Neomangiferin partially ameliorates non-alcoholic fatty liver disease (NAFLD) by regulating the expression of genes related to free fatty acid uptake and lipid oxidation. Neomangiferin exerts anti-colitis effects by inhibiting Th17/Treg cell differentiation. Neomangiferin exerts anti-aging and lifespan-extending effects by targeting upregulation of bas-1, which in turn activates the autophagy, IIS and MAPK pathways. Neomangiferin has the potential to prevent aseptic loosening of prostheses after total joint arthroplasty due to its significant anti-inflammatory and osteoclastogenesis-inhibiting effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111143
CAS No.: 915210-50-3
Purity:  98.64%
Target:  

nAChR

Research Areas:  

Metabolic Disease

SCH-900271 is an orally active, potent nicotinic acid receptor (NAR) agonist with an EC50 of 2 nM in the hu-GPR109a assay. SCH-900271 exhibits dose-dependent inhibition of plasma free fatty acid (FFA) .
loading...
    loading...